DE69715358D1 - Topische Zusammensetzung enhaltend Pulver aus Safflorsamen zur Behandlung von rheumatoiden Arthritis Krankheiten und Menopause - Google Patents

Topische Zusammensetzung enhaltend Pulver aus Safflorsamen zur Behandlung von rheumatoiden Arthritis Krankheiten und Menopause

Info

Publication number
DE69715358D1
DE69715358D1 DE69715358T DE69715358T DE69715358D1 DE 69715358 D1 DE69715358 D1 DE 69715358D1 DE 69715358 T DE69715358 T DE 69715358T DE 69715358 T DE69715358 T DE 69715358T DE 69715358 D1 DE69715358 D1 DE 69715358D1
Authority
DE
Germany
Prior art keywords
menopause
treatment
composition containing
rheumatoid arthritis
topical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69715358T
Other languages
English (en)
Inventor
Parvin Youssefyeh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE69715358D1 publication Critical patent/DE69715358D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/286—Carthamus (distaff thistle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
DE69715358T 1996-12-03 1997-11-26 Topische Zusammensetzung enhaltend Pulver aus Safflorsamen zur Behandlung von rheumatoiden Arthritis Krankheiten und Menopause Expired - Lifetime DE69715358D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/753,926 US5753266A (en) 1996-12-03 1996-12-03 Safflower seed powder compositions for the treatment of rheumatoid based arthritic diseases
CA002223817A CA2223817C (en) 1996-12-03 1997-12-05 Compositions for the treatment of rheumatoid-based arthritic diseases

Publications (1)

Publication Number Publication Date
DE69715358D1 true DE69715358D1 (de) 2002-10-17

Family

ID=33435752

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69715358T Expired - Lifetime DE69715358D1 (de) 1996-12-03 1997-11-26 Topische Zusammensetzung enhaltend Pulver aus Safflorsamen zur Behandlung von rheumatoiden Arthritis Krankheiten und Menopause

Country Status (5)

Country Link
US (2) US5753266A (de)
EP (1) EP0846466B1 (de)
AU (1) AU698509B2 (de)
CA (1) CA2223817C (de)
DE (1) DE69715358D1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753266A (en) * 1996-12-03 1998-05-19 Youssefyeh; Parvin Safflower seed powder compositions for the treatment of rheumatoid based arthritic diseases
US6245340B1 (en) * 1996-12-03 2001-06-12 Parvin Youssefyeh Method of improving the immune response and compositions therefor
US6497890B2 (en) * 1996-12-03 2002-12-24 Parvin Youssefyeh Anti-wrinkle preparation and method of reducing wrinkles in facial skin and neck
US6362227B1 (en) * 1999-03-02 2002-03-26 Sepracor, Inc. Methods for the treatment of tinnitus and other disorders using R(−)ketoptofen
US6083933A (en) * 1999-04-19 2000-07-04 Stellar International Inc. Treatment of cystitis-like symptoms with chondroitin sulfate following administration of a challenge solution
US6337076B1 (en) * 1999-11-17 2002-01-08 Sg Licensing Corporation Method and composition for the treatment of scars
SE0001440D0 (sv) * 2000-04-18 2000-04-18 Entretech Medical Ab A drug against climacteric disorders
US6866874B2 (en) 2000-05-26 2005-03-15 Susan P. Hudson Tryptophan source from plants and uses therefor
US6503543B1 (en) * 2000-05-26 2003-01-07 Craig J. Hudson Tryptophan source from plants and uses therefor
FR2819404B1 (fr) * 2001-01-12 2004-11-05 Oreal Compositions cosmetiques contenant un fructane et un polymere cationique et leurs utilisations
US6528076B2 (en) 2001-07-06 2003-03-04 Magic Herb Corp. Topical compositions and methods for treating pain
US7066006B2 (en) * 2002-07-02 2006-06-27 Kimberly-Clark Worldwide, Inc. Method of collecting data relating to attributes of personal care articles and compositions
US7195790B2 (en) * 2002-12-09 2007-03-27 Shaklee Corporation Modification of cyclooxygenase and lipoxygenase activity with asteridae extracts and optionally boswellic acid
US7981877B2 (en) 2003-01-23 2011-07-19 Patel Pravin M Stabilized steroid composition and method for its preparation
US7378405B2 (en) * 2003-01-23 2008-05-27 Triax Pharmaceuticals, Llc Stabilized steroid composition and method for its preparation
TWI322691B (en) * 2003-04-11 2010-04-01 Follicle-stimulating hormone reducing agent
TWI350759B (en) * 2003-04-18 2011-10-21 A promoting agent of producing granulocyte/macrophage colony stimulating factor
CN101184780B (zh) 2005-05-05 2012-10-03 森馨香料公司 β-葡聚糖和甘露聚糖的制备
JP2007124088A (ja) * 2005-10-26 2007-05-17 Olympus Corp 画像撮影装置
ES2389743T3 (es) * 2006-04-22 2012-10-31 Harbor Biosciences, Inc. Medicamentos y usos
EP2184997A4 (de) * 2007-07-31 2010-11-03 Univ New York Diagnose- und behandlungsverfahren für die charakterisierung von bakteriellen mikroorganismen bei hautkrankheiten
WO2009143309A2 (en) * 2008-05-21 2009-11-26 Trustees Of Dartmouth College Female reproductive tract and anal prophylaxes
US8894630B2 (en) * 2009-11-13 2014-11-25 The Invention Science Fund I, Llc Device, system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject
US8784368B2 (en) * 2009-11-13 2014-07-22 The Invention Science Fund I, Llc Device, system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject
US8439896B2 (en) * 2009-11-13 2013-05-14 The Invention Science Fund I, Llc Device, system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject
US8795640B2 (en) 2011-12-22 2014-08-05 Mary Kay Inc. Lip formulation
CN104689144A (zh) * 2013-12-09 2015-06-10 黄思齐 一种治疗风湿性关节炎的药物
CN103768230B (zh) * 2014-02-08 2016-05-18 史红梅 一种治疗类风湿性关节炎的中药熏洗剂
CN104857169A (zh) * 2015-06-22 2015-08-26 李万红 蛇毒、五香软膏贴
CN104873702A (zh) * 2015-06-22 2015-09-02 李万红 蛇毒-红灵软膏贴
KR102150114B1 (ko) * 2018-09-28 2020-09-01 대한민국 편각영지버섯 추출물, 잇꽃씨 추출물 또는 이의 혼합물을 유효성분으로 포함하는 관절염 예방, 개선 또는 치료용 조성물

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2978381A (en) * 1958-06-20 1961-04-04 Freedman Louis Process and composition for lowering blood serum cholesterol and chylomicron levels
US3584129A (en) * 1968-12-05 1971-06-08 Joseph R Kitson Preparation of a composition for the relief of arthritic pains
US4009290A (en) * 1974-02-11 1977-02-22 Nisshin Seiyu Kabushiki Kaisha Method for preparing edible oil
US4072669A (en) * 1977-03-07 1978-02-07 The United States Of America As Represented By The Secretary Of Agriculture Preparation of protein isolates from safflower seeds
US4623539A (en) * 1983-02-04 1986-11-18 Tunc Deger C Nutrient barrier polysaccharide compositions and method of use
US4806354A (en) * 1984-04-06 1989-02-21 Green James P Health food composition
US4981844A (en) * 1988-10-04 1991-01-01 University Of Cincinnati Method to improve immune response and resistance to infection following surgery by diet composition
US4898721A (en) * 1989-04-04 1990-02-06 Alway Robert M Halogen absorbtion using vegetable oils and surfactants
GB2230446A (en) * 1989-04-12 1990-10-24 Cerro Continental S A Pediculicidal compositions
US5063062A (en) * 1989-09-27 1991-11-05 D. Greenspan Cleaning compositions with orange oil
US5162113A (en) * 1991-05-15 1992-11-10 Oh Jung M Oral composition for treating bone disorders
US5436386A (en) * 1993-10-05 1995-07-25 Seedtec International Inc. Hybrid safflower production utilizing genetic dwarf male sterility
US5397778A (en) * 1994-02-25 1995-03-14 New England Deaconess Hospital Corporation Enteral formulations for treatment of inflammation and infection
CN1130074A (zh) * 1995-03-01 1996-09-04 李凤欣 慢性风湿症骨质增生病外敷药
US5753266A (en) * 1996-12-03 1998-05-19 Youssefyeh; Parvin Safflower seed powder compositions for the treatment of rheumatoid based arthritic diseases

Also Published As

Publication number Publication date
CA2223817C (en) 2001-10-23
EP0846466A3 (de) 1998-09-23
EP0846466B1 (de) 2002-09-11
AU4539097A (en) 1998-06-04
US5968519A (en) 1999-10-19
US5753266A (en) 1998-05-19
AU698509B2 (en) 1998-10-29
EP0846466A2 (de) 1998-06-10
CA2223817A1 (en) 1999-06-05

Similar Documents

Publication Publication Date Title
DE69715358D1 (de) Topische Zusammensetzung enhaltend Pulver aus Safflorsamen zur Behandlung von rheumatoiden Arthritis Krankheiten und Menopause
ATE255888T1 (de) Tetrahydronaphtalene verbindungen und deren verwendung zur behandlung von neurodegenerativen krankheiten
DE69315257D1 (de) Simethicon enthaltende Arzneimittel zur Behandlung gastrointestinaler Störungen
ATE236529T1 (de) Antiparasitäre zusammensetzung zur behandlung und zum schutz von haustieren
DE69836752D1 (de) Prostaglandinagoniste und deren verwendung zur behandlung von knochenerkrankungen
DE69312624D1 (de) Vorrichtung zur unterscheidung von tachykardien und fibrillationen und zur entsprechenden behandlung
HUP0300836A3 (en) Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
GB9206736D0 (en) Improvements of organic compounds and their use in pharmaceutical compositions
DE69422635D1 (de) Energiehärtbare Zusammensetzungen aus Cyanaten und ethylenisch ungesättigten Verbindungen
DE69906671D1 (de) Substituierte 2-Phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanone, deren Verwendung zur Behandlung von Erkrankungen des zentralen und periphären Nervensystems und diese enthaltende pharmazeutische Zusammensetzungen
ATE331522T1 (de) Zusammensetzung zur behandlung von atemwegs- und hauterkrankungen mit mindestens einem leukotrienantagonist und mindestens einem antihistaminikum
DE69509544D1 (de) Zusammensetzung zur behandlung ovarieller östrogenabhängiger krankheiten
DE69332732D1 (de) Pharmazeutische Zusammensetzung und Methode zur Behandlung von Hyperlipidämie und Arterioskerose
DE69729284D1 (de) Filmbildende zusammensetzungen von antihyperalgesischen opiaten und deren verwendung zur behandlung von hyperalgesie
FI972433A0 (fi) Rantes-peptidi ja fragmentteja sekä tätä sisältäviä tulehduksen hoitoon soveltuvia koostumuksia
DE69812784D1 (de) Zusammensetzung zur Vorbeugung und Beseitigung von Pflanzenkrankheiten
DE69841984D1 (de) Zusammensetzung aus nanokapseln zur behandlung von intraarticulaeren erkrankungen
ATE215373T1 (de) 21-hydro-6,19-oxidoprogesterone (21oh-60p) und deren verwendung als arzneimittel zur behandlung von glukokortikoidüberschuss
DE19580261D2 (de) Pharmazeutische Zubereitungen und Arzneistoffe zur Prävention und Behandlung endothelialer Dysfunktion
DE69532066D1 (de) Arzneimittel zur Behandlung von Restenosis und Gefässsklerose
DE69600983D1 (de) Kapselpräparate zur Behandlung von Pflanzen
DE69912670D1 (de) Substituierte tricyclische Verbindungen und deren Verwendung zur Behandlung von sPLA2-bedingten Erkrankungen
ATE258062T1 (de) Verwendung von wachstumshormon freisetzenden stoffen und ihren antagonisten zur behandlung von tumoren
DE69825319D1 (de) Präparat zur vorbeugung und behandlung von entzündungen
DE69420229D1 (de) Pharmazeutische Zusammensetzung zur Behandlung von AIDS

Legal Events

Date Code Title Description
8332 No legal effect for de